Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf is a New York Plaintiff's personal injury law firm specializing in automobile accidents, construction accidents, medical malpractice, products liability, police misconduct and all types of New York personal injury litigation.

Articles Tagged with product liability

Published on:

By

Our Partner, Anthony Gair will be speaking at LITIGATING THE PRODUCTS LIABILITY CASE: LAW AND PRACTICE NYC seminar presented by the New York State Bar Association. The Chair of the Seminar is Dennis J. Brady, Esq. a Partner at the preeminent New York defense firm, Goldberg Segalla LLP.
The Seminar will be held on Thursday, October 24, 2013 from 9:00 AM – 5:00 PM at The Holiday Inn Manhattan 440 W. 57th Street New York, NY 10019.

Other speakers are:

Brian T. Stapleton, Esq., Goldberg Segalla LLP, White Plains, NY David M. Glazer, Esq., Patterson Belknap, New York, NY Hon. John P. DiBlasi, White Plains, NY Brian Isaac, Esq., Pollack Pollack Isaac & Decicco, New York, NY Ellen H. Greiper, Esq., Goldberg Segalla, LLP John J. McDonough, III, Esq., Cozen O’Connor, New York, NY
To Register click here.

The Agenda for the Seminar is below.
Continue reading →

Published on:

By

Products%20with%20hidden%20drug%20ingredients%20Dr%20Mao.jpgHidden Drugs or Chemicals in dietary supplements or conventional food can cause severe personal injury and sometimes lead to death. According to the FDA, some products promoting sexual enhancement, weight loss, or bodybuilding and advertised as “all natural” may contain dangerous drugs or chemicals that have been previously removed from the market for safety reason.

For example, The FDA announced recently that Sibutramine was found in several weight loss products. These products go by the name of “Dr. Mao Slimming Capsules”, “Be Inspired”, “Perfect Body Solutions” and “Burn 7”, “Bella Vi Insane Amp’d” and “Bella Vi Amp’d Up”

Sibutramine is a controlled substance that was removed from the market in 2010 because it can increase blood pressure and/or pulse rate in some patients. Sibutramine can present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Sibutramine can also interact in life-threatening ways with other medications.

Published on:

By

Red%20and%20Grenn%20Bell%20Peppers.jpgOrange County produce is recalling three lots containing 1,208 cartons of 25 peppers. They were distributed to farmer’s markets and wholesale food service in Southern California between September 21st and 24th. The bell pepper are being recalled after a random sample of OC Produce Bell Peppers tested positive for Salmonella.

Read more in Food Safety News

Published on:

By

Fentanyl.jpgThe FDA has received several reports of wrongful death, including two children since April 2012 when it warned the public about the danger of accidental exposure to fentanyl patches. For this reason, manufacturers are now required to use a more visible ink to print the name and the strength of the drug on the patches.

Exposure to fentanyl patches can cause serious injury and death to children, pets and others.

Accidental exposure may happen if a used patch is not disposed of properly or if a patch accidentally falls from a patients skin.

Continue reading →
Published on:

By

2005-Toyota-Sienna.jpgToyota announced a new car recall in the US yesterday because a defective lever system in some Sienna minivans can cause the vehicles to shift out of park mode “without the driver depressing the brake pedal” and resulting in a vehicle roll-away. 24 accidents related to the defective car have been reported to Toyota so far. The recall affects approximately 615,000 Sienna minivans from Model Years 2004-2005 and 2007-2009. This is the second time in a month that Toyota has issued a recall of its vehicles in the US market. Earlier this month, the car manufacturer issued a recall for more than 780,000 vehicles to address a defective suspension in its RAV4 and Lexus HS 250h models.

Nissan also announced yesterday that it was recalling nearly a million defective cars worldwide because a defective accelerator sensor could cause the car to stall. No accidents have been reported so far according to the manufacturer. The recall affects Infiniti M, Serena, X-Trail, Lafesta and Fuga models produced in Japan between 2004 and 2013.

Published on:

By

A new study published in CANCER, a peer-reviewed journal of the American Cancer Society, shows that Amioradone, marketed since 1985 and used for arrhythmia or irregular heartbeats may increase cancer especially for patient using large doses.

  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
Badges
Super Lawyers Best Lawyers Martindale-Hubbell
SEE NEW JERSEY DISCLAIMER PAGE- AWARD METHODOLOGY